StockData
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. (TNYA) stock

TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$0.32−0.01 (-3.24%)

Close on Nov 17, 2026Market cap $72.38MP/E –Yield –

Tenaya Therapeutics cash

Cash and short-term investments held at the end of each period.

Tenaya Therapeutics's cash was $78.10M at Jun 30, 2026. For fiscal 2025 it was $100.50M, up 63.7% from the year before. The highest annual figure on record is $251.30M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$100.50M+63.7%
FY2024Dec 31, 2024$61.40M-41.3%
FY2023Dec 31, 2023$104.60M-48.8%
FY2022Dec 31, 2022$204.20M-18.7%
FY2021Dec 31, 2021$251.30M+95.5%
FY2020Dec 31, 2020$128.54M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$78.10M+8.9%
Q1 FY2026Mar 31, 2026$80.90M-8.3%
Q4 FY2025Dec 31, 2025$100.50M+63.7%
Q3 FY2025Sep 30, 2025$56.30M-29.2%
Q2 FY2025Jun 30, 2025$71.70M-27.8%
Q1 FY2025Mar 31, 2025$88.20M-27.8%
Q4 FY2024Dec 31, 2024$61.40M-41.3%
Q3 FY2024Sep 30, 2024$79.50M-37.9%
Q2 FY2024Jun 30, 2024$99.30M-34.5%
Q1 FY2024Mar 31, 2024$122.20M-29.6%
Q4 FY2023Dec 31, 2023$104.60M-48.8%
Q3 FY2023Sep 30, 2023$128.10M-14.3%
Q2 FY2023Jun 30, 2023$151.60M-16.2%
Q1 FY2023Mar 31, 2023$173.60M-18.7%
Q4 FY2022Dec 31, 2022$204.20M-18.7%
Q3 FY2022Sep 30, 2022$149.50M-46.7%
Q2 FY2022Jun 30, 2022$180.90M+61.7%
Q1 FY2022Mar 31, 2022$213.50M+66.2%
Q4 FY2021Dec 31, 2021$251.30M+95.5%
Q3 FY2021Sep 30, 2021$280.50M+357.3%
Q2 FY2021Jun 30, 2021$111.89M+177.4%
Q1 FY2021Mar 31, 2021$128.44M–
Q4 FY2020Dec 31, 2020$128.54M–
Q3 FY2020Sep 30, 2020$61.34M–
Q2 FY2020Jun 30, 2020$40.34M–

More Tenaya Therapeutics figures

See a number that looks wrong?